Producing a Joint Formulary


The BCAP Formulary is intended for use in the treatment of Adolescents and Adults only

The Joint Formulary is co-ordinated by a small group of primary and secondary care representatives including GPs, consultants and pharmacists. The Joint Formulary Group, in collaboration with relevant specialists, develops the chapters.

To support education, reduction of errors and stock control the formulary will not include all licensed products in a class. When choosing a drug for inclusion in the formulary, the agent with the widest range of therapeutic indications and best quality published evidence showing clinically beneficial outcomes will be chosen. In most cases a maximum of 2-3 drugs of the same class will be sufficient to cover 80-90% of prescribing.

New Drugs

Alternative choices of drugs or requests for additions to the formulary will be considered by the BCAP PTC. Acute trust-only drugs with no implications for primary care will be considered by the RUH Drug Policy Group.

The Technical Group would be pleased to receive requests and comments from clinicians and pharmacists to ensure that choices are appropriate and up to date. Requests should be made on the appropriate forms to the lead pharmacists

Prescribing for children - See BCAP Traffic Light Scheme for advice on prescribing for children and the BNF for children

Keeping up to date

Each chapter, with the exception of Chapter 5 Infections, is scheduled for review every two years, but reviews may be more frequent if compelling NEW evidence becomes available. The review process follows a similar pattern of wide consultation as the initial chapter production.

Changes to a chapter may occasionally become necessary between reviews, for example, when the Drug Policy Group (DPG) approve new therapies, or a drug is withdrawn from supply. These changes will be made within 3 months of the Joint Formulary Committee agreement on the web-based version of the formulary.

If you would like help implementing the Joint Formulary...

please contact:

  • Primary care: your Primary Care Trust Prescribing Team
  • Secondary care: the Pharmacy or your directorate pharmacist.

Last updated by: Joy Craine on 08-07-2014 12:32